In Vitro Activity of Rifaximin against Enteropathogens Producing Traveler's Diarrhea
Open Access
- 1 February 2001
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 45 (2) , 643-644
- https://doi.org/10.1128/aac.45.2.643-644.2001
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- In Vitro Activity and Fecal Concentration of Rifaximin after Oral AdministrationAntimicrobial Agents and Chemotherapy, 2000
- Tropical and exotic infectionsJournal of Medical Microbiology, 2000
- Antimicrobial Resistance of Diarrheagenic Escherichia coli Isolated from Children under the Age of 5 Years from Ifakara, TanzaniaAntimicrobial Agents and Chemotherapy, 1999
- Rifaximin: A Nonabsorbed Antimicrobial in the Therapy of Travelers’ DiarrheaDigestion, 1998
- Campylobacter jejuni as a Cause of Traveler's Diarrhea: Clinical Features and Antimicrobial SusceptibilityJournal of Travel Medicine, 1998
- RifaximinDrugs, 1995
- Antimicrobial Resistance of NontyphoidalSalmonellaIsolates in Traveler's DiarrheaJournal of Travel Medicine, 1995
- Etiology of traveller's diarrhea in Spanish travellers to developing countriesEuropean Journal of Epidemiology, 1993
- Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivativeDiagnostic Microbiology and Infectious Disease, 1993
- INVITRO ANTIBACTERIAL ACTIVITY OF RIFAXIMIN AGAINST CLOSTRIDIUM-DIFFICILE, CAMPYLOBACTER-JEJUNII AND YERSINIA SPP1987